Christina Rossi's Net Worth
$4.63 Million
Who is Christina Rossi?
Christina Rossi has an estimated net worth of $4.63 Million. This is based on reported shares across multiple companies, which include Blueprint Medicines Corp, and Xilio Therapeutics, Inc..
SEC CIK
Christina Rossi's CIK is 0001756941
Past Insider Trading and Trends
2019 was Christina Rossi's most active year for acquiring shares with 4 total transactions. Christina Rossi's most active month to acquire stocks was the month of February. 2021 was Christina Rossi's most active year for disposing of shares, totalling 3 transactions. Christina Rossi's most active month to dispose stocks was the month of February. 2018 saw Christina Rossi paying a total of $0.00 for 84,500 shares, this is the most they've acquired in one year. In 2023 Christina Rossi cashed out on 3,059 shares for a total of $139,714.92, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Blueprint Medicines Corp (BPMC) Snapshot price: $74.43
CHIEF OPERATING OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.63% | -6.07K |
$90.69 | -$550,488.30 | 64.31K |
Mar 7
| |||
Form 4
| +27.09% | 15K |
—
|
—
| 70.38K |
Mar 1
| |||
Form 4
| -5.23% | -3.06K |
$45.67 | -$139,714.92 | 55.38K |
Mar 6
| |||
Form 4
| +34.53% | 15K |
—
|
—
| 58.44K |
Mar 1
| |||
Form 4
| -1.21% | -533.00 |
$45.24 | -$24,112.92 | 43.44K |
Nov 3
| |||
Form 4
| -1.15% | -511.00 |
$110.85 | -$56,644.35 | 43.97K |
Nov 3
| |||
Form 4
| -4.80% | -2.24K |
$58.37 | -$130,986.09 | 44.48K |
Mar 3 - Mar 7
| |||
Form 4
| +47.28% | 15K |
—
|
—
| 46.72K |
Mar 1
| |||
Form 4
| -4.11% | -1.36K |
$86.77 | -$117,919.62 | 31.72K |
Mar 4
| |||
Form 4
| +65.24% | 13.06K |
—
|
—
| 33.08K |
Mar 1
| |||
Form 4
| -1.69% | -345.00 |
$99.69 | -$34,393.05 | 20.02K |
Nov 3
| |||
Form 4
| -0.66% | -135.00 |
$51.96 | -$7,014.60 | 20.36K |
Mar 9
| |||
Form 4
| +228.00% | 14.25K |
—
|
—
| 20.5K |
Mar 1
| |||
Form 4
|
∞
| 1.13K |
—
|
—
| 1.13K |
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.6382
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||